2-232087576-A-G

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_152383.5(DIS3L2):​c.456A>G​(p.Gln152Gln) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0818 in 1,613,826 control chromosomes in the GnomAD database, including 6,444 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.11 ( 1098 hom., cov: 31)
Exomes 𝑓: 0.079 ( 5346 hom. )

Consequence

DIS3L2
NM_152383.5 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 0.0330

Publications

11 publications found
Variant links:
Genes affected
DIS3L2 (HGNC:28648): (DIS3 like 3'-5' exoribonuclease 2) The protein encoded by this gene is similar in sequence to 3'/5' exonucleolytic subunits of the RNA exosome. The exosome is a large multimeric ribonucleotide complex responsible for degrading various RNA substrates. Several transcript variants, some protein-coding and some not, have been found for this gene. [provided by RefSeq, Mar 2012]
DIS3L2 Gene-Disease associations (from GenCC):
  • Perlman syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Orphanet, Labcorp Genetics (formerly Invitae), G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant 2-232087576-A-G is Benign according to our data. Variant chr2-232087576-A-G is described in ClinVar as Benign. ClinVar VariationId is 262632.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.033 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.184 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DIS3L2NM_152383.5 linkc.456A>G p.Gln152Gln synonymous_variant Exon 6 of 21 ENST00000325385.12 NP_689596.4 Q8IYB7-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DIS3L2ENST00000325385.12 linkc.456A>G p.Gln152Gln synonymous_variant Exon 6 of 21 5 NM_152383.5 ENSP00000315569.7 Q8IYB7-1

Frequencies

GnomAD3 genomes
AF:
0.108
AC:
16473
AN:
151940
Hom.:
1094
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.187
Gnomad AMI
AF:
0.185
Gnomad AMR
AF:
0.114
Gnomad ASJ
AF:
0.0963
Gnomad EAS
AF:
0.0370
Gnomad SAS
AF:
0.107
Gnomad FIN
AF:
0.0700
Gnomad MID
AF:
0.0665
Gnomad NFE
AF:
0.0708
Gnomad OTH
AF:
0.101
GnomAD2 exomes
AF:
0.0954
AC:
23805
AN:
249446
AF XY:
0.0915
show subpopulations
Gnomad AFR exome
AF:
0.192
Gnomad AMR exome
AF:
0.165
Gnomad ASJ exome
AF:
0.0987
Gnomad EAS exome
AF:
0.0357
Gnomad FIN exome
AF:
0.0645
Gnomad NFE exome
AF:
0.0729
Gnomad OTH exome
AF:
0.0848
GnomAD4 exome
AF:
0.0790
AC:
115504
AN:
1461770
Hom.:
5346
Cov.:
32
AF XY:
0.0789
AC XY:
57387
AN XY:
727180
show subpopulations
African (AFR)
AF:
0.194
AC:
6485
AN:
33476
American (AMR)
AF:
0.163
AC:
7282
AN:
44716
Ashkenazi Jewish (ASJ)
AF:
0.0963
AC:
2516
AN:
26136
East Asian (EAS)
AF:
0.0340
AC:
1348
AN:
39696
South Asian (SAS)
AF:
0.107
AC:
9226
AN:
86244
European-Finnish (FIN)
AF:
0.0685
AC:
3658
AN:
53416
Middle Eastern (MID)
AF:
0.0766
AC:
442
AN:
5768
European-Non Finnish (NFE)
AF:
0.0714
AC:
79411
AN:
1111928
Other (OTH)
AF:
0.0850
AC:
5136
AN:
60390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.463
Heterozygous variant carriers
0
5477
10954
16430
21907
27384
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
3118
6236
9354
12472
15590
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.109
AC:
16499
AN:
152056
Hom.:
1098
Cov.:
31
AF XY:
0.107
AC XY:
7979
AN XY:
74348
show subpopulations
African (AFR)
AF:
0.187
AC:
7752
AN:
41444
American (AMR)
AF:
0.114
AC:
1748
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
0.0963
AC:
334
AN:
3470
East Asian (EAS)
AF:
0.0363
AC:
188
AN:
5182
South Asian (SAS)
AF:
0.106
AC:
512
AN:
4822
European-Finnish (FIN)
AF:
0.0700
AC:
741
AN:
10590
Middle Eastern (MID)
AF:
0.0680
AC:
20
AN:
294
European-Non Finnish (NFE)
AF:
0.0708
AC:
4815
AN:
67966
Other (OTH)
AF:
0.105
AC:
222
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
733
1466
2200
2933
3666
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
182
364
546
728
910
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0894
Hom.:
566
Bravo
AF:
0.116
Asia WGS
AF:
0.100
AC:
348
AN:
3478
EpiCase
AF:
0.0697
EpiControl
AF:
0.0668

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Perlman syndrome Benign:2
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not provided Benign:2
Feb 24, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
0.99
DANN
Benign
0.39
PhyloP100
0.033
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11887184; hg19: chr2-232952286; COSMIC: COSV108017957; COSMIC: COSV108017957; API